Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Angus, C.R.; Thomas, C.; Anderson, P.; Meier, P.; Brennan, A. (2017)
Publisher: Oxford University Press
Languages: English
Types: Article

Classified by OpenAIRE into

mesheuropmc: health care economics and organizations
Background\ud Screening and Brief Interventions for alcohol are an effective public health measure to tackle\ud alcohol-related harm, however relatively few countries across the European Union (EU) have\ud implemented them widely. This may be due to a lack of understanding of the specific financial\ud implications of such policies within each country.\ud Methods\ud A novel ‘meta-modelling’ approach was developed based on previous SBI cost-effectiveness models\ud for four EU countries. Data was collected on the key factors which drive cost-effectiveness for all 28\ud EU countries (mean per capita alcohol consumption, proportion of the population to be screened\ud over a 10-year SBI programme; per capita alcohol-attributable mortality; per capita alcoholattributable\ud morbidity; mean cost of an alcohol-related hospitalisation and mean SBI-delivery staff\ud cost). Regression analysis was used to fit two meta-models estimating net programme costs and\ud quality-adjusted life-years (QALYs) gained, to calculate cost-effectiveness estimates specific to each\ud EU country.\ud Results\ud Costs are dependent upon the proportion of the population covered by the screening programme,\ud the country-specific per capita mortality and morbidity rate and the country-specific costs of GP care\ud and hospitalisation. QALYs depend on the proportion of the population screened and per capita\ud alcohol consumption. Despite large inter-country variability in factor values, SBI programmes are\ud likely to be cost-effective in 24 out of 28 EU countries and cost-saving in about 50% of countries.\ud Conclusion\ud Implementing national programmes of SBI in primary health care would be a cost-effective means of\ud reducing alcohol-attributable morbidity and deaths in almost all countries of the EU.

Share - Bookmark

Funded by projects

  • EC | ODHIN

Cite this article